Recent Content
DOAR Releases Results from a National Survey of Jurors’ Attitudes Toward Pharmaceutical Companies
May 14, 2024, New York, NY—DOAR, the nation’s leading trial consulting company, today released important findings from a new national study that examines several issues suspected of influencing jurors’ baseline attitudes toward pharmaceutical companies. The findings indicate that opinions of the pharmaceutical industry are generally favorable despite a prevailing view of it as profit-centric. The […]
DOAR’s Natalie Gordon helps lawyers uncover juror attitudes on high-stakes matters
DOAR Consultant Natalie Gordon, Ph.D., is a well-regarded jury consultant with experience working on complex civil and white collar criminal cases. She has contributed to many high-stakes matters, including U.S. v. Tom Barrack, Ambac v. Countrywide, US v. Jayson Penn, Monster Energy Co. v. Vital Pharmaceuticals, and SEC v. AT&T et. al., to name a […]